Ac-EYLFEVDNL-NH2

Ref. 3D-PP44034

Informations sur le produit

• Nom: Ac-EYLFEVDNL-NH2
• Synonymes: Ac-Glu-Tyr-Leu-Phe-Glu-Val-Asp-Asn-Leu-amide

Description

Peptide Ac-EYLFEVDNL-NH2 is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using Ac-EYLFEVDNL-NH2 include the following: Efficacy of parainfluenza virus 5 mutants expressing hemagglutinin from H5N1 influenza A virus in mice Z Li , JD Gabbard, A Mooney, Z Chen - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.01289-13 Single-dose vaccination of a recombinant parainfluenza virus 5 expressing NP from H5N1 virus provides broad immunity against influenza A viruses Z Li , JD Gabbard, A Mooney, X Gao, Z Chen - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.00120-13 Recombinant parainfluenza virus 5 expressing hemagglutinin of influenza A virus H5N1 protected mice against lethal highly pathogenic avian influenza virus H5N1 Z Li , AJ Mooney, JD Gabbard, X Gao, P Xu - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02321-12 Influences of glycosylation on antigenicity, immunogenicity, and protective efficacy of ebola virus GP DNA vaccines W Dowling, E Thompson, C Badger - Journal of , 2007 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.02098-06 Induction of immune responses in mice and monkeys to Ebola virus after immunization with liposome-encapsulated irradiated Ebola virus: protection in mice requires M Rao, M Bray, CR Alving, P Jahrling - Journal of , 2002 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.76.18.9176-9185.2002 In silico prediction of Ebola Zaire GP1,2 immuno-dominant epitopes for the Balb/c mouse DK Dutta, K Rhodes , SC Wood - BMC immunology, 2015 - Springerhttps://link.springer.com/article/10.1186/s12865-015-0126-8 RECOMBINANT PIV5 VACCINE PROTECTS AGAINST HPAI H5N1 INFECTION WHEN DELIVERED INTRANASALLY OR INTRAMUSCULARLY. AJ Mooney, Z Li, JD Gabbard, DA Dlugolenski - PIV5 AS A NOVEL - getd.libs.uga.eduhttps://getd.libs.uga.edu/pdfs/mooney_alaina_j_201205_phd.pdf#page=194 VACCINATION WITH RECOMBINANT PIV5 EXPRESSING NEURAMINIDASE PROVIDES HOMOLOGOUS AND HETEROLOGOUS PROTECTION AGAINST AJ Mooney, Z Li, JD Gabbard, DA Dlugolenski - PIV5 AS A NOVEL - getd.libs.uga.eduhttp://getd.libs.uga.edu/pdfs/mooney_alaina_j_201205_phd.pdf#page=161 PROTECTION AGAINST H5N1 VIRUS CHALLENGE BY IMMUNIZATION WITH RECOMBINANT PIV5 EXPRESSING HA OF H5N1 (rPIV5-H5) AJ Mooney, Z Li, JD Gabbard, DA Dlugolenski - PIV5 AS A NOVEL - getd.libs.uga.eduhttp://getd.libs.uga.edu/pdfs/mooney_alaina_j_201205_phd.pdf#page=113 Recombinant parainfluenza virus 5 vaccine encoding the influenza virus hemagglutinin protects against H5N1 highly pathogenic avian influenza virus infection AJ Mooney, Z Li , JD Gabbard, B He - Journal of , 2013 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/JVI.02330-12 Vaccination with recombinant parainfluenza virus 5 expressing neuraminidase protects against homologous and heterologous influenza virus challenge AJ Mooney, JD Gabbard, Z Li , DA Dlugolenski - Journal of , 2017 - Am Soc Microbiolhttps://journals.asm.org/doi/abs/10.1128/jvi.01579-17

• Marque: Biosynth